Pub Date : 2026-01-01Epub Date: 2024-06-17DOI: 10.1097/SLA.0000000000006396
Lena Florinett, Andreas Widmer, Nicolas Troillet, Guido Beldi, Markus Von Flüe, Stephan Harbarth, Rami Sommerstein
Objective: To assess whether administration of surgical antimicrobial prophylaxis (SAP) versus absence of SAP is associated with a decreased risk of surgical site infections (SSIs) after low-risk cholecystectomies (LR-CCEs).
Background: Current guidelines do not recommend routine SAP administration before LR-CCE.
Methods: This cohort study included adult patients who underwent LR-CCE and were documented by the Swissnoso SSI surveillance system between January 2009 and December 2020 at 66 Swiss hospitals. LR-CCE was specified as elective endoscopic surgery, age <70, no active cholecystitis, ASA score <3, operating time <120 minutes without implantation of foreign material. Exposure was defined as the administration of cefuroxime or cefazoline ± metronidazole within 120 minutes before incision versus no SAP administration. Our main outcome was the occurrence of SSI until day 30. Logistic regression models were used to adjust for institutional, patient, and perioperative variables.
Results: Of 44,682 surveilled adult patients undergoing cholecystectomy, 12,521 [8726 women (69.7%); median (interquartile range) age, 49.0 (38.1-58.2) years] fulfilled the inclusion criteria. SSI was identified in 143 patients (1.1%). SAP was administered in 9269 patients (74.0%) and was associated with a lower SSI rate (adjusted odds ratio, 0.50; 95% CI, 0.35-0.70; P < 0.001). The number needed to treat to prevent 1 SSI episode is 100.
Conclusions: The overall LR-CCE SSI rate was 1.1%. SAP was associated with a 50% lower overall SSI rate. Patients undergoing LR-CCE may benefit from routine SAP.
{"title":"Surgical Antimicrobial Prophylaxis in Low-risk Cholecystectomies is Associated With Fewer Surgical Site Infections: Nationwide Cohort Study in Switzerland.","authors":"Lena Florinett, Andreas Widmer, Nicolas Troillet, Guido Beldi, Markus Von Flüe, Stephan Harbarth, Rami Sommerstein","doi":"10.1097/SLA.0000000000006396","DOIUrl":"10.1097/SLA.0000000000006396","url":null,"abstract":"<p><strong>Objective: </strong>To assess whether administration of surgical antimicrobial prophylaxis (SAP) versus absence of SAP is associated with a decreased risk of surgical site infections (SSIs) after low-risk cholecystectomies (LR-CCEs).</p><p><strong>Background: </strong>Current guidelines do not recommend routine SAP administration before LR-CCE.</p><p><strong>Methods: </strong>This cohort study included adult patients who underwent LR-CCE and were documented by the Swissnoso SSI surveillance system between January 2009 and December 2020 at 66 Swiss hospitals. LR-CCE was specified as elective endoscopic surgery, age <70, no active cholecystitis, ASA score <3, operating time <120 minutes without implantation of foreign material. Exposure was defined as the administration of cefuroxime or cefazoline ± metronidazole within 120 minutes before incision versus no SAP administration. Our main outcome was the occurrence of SSI until day 30. Logistic regression models were used to adjust for institutional, patient, and perioperative variables.</p><p><strong>Results: </strong>Of 44,682 surveilled adult patients undergoing cholecystectomy, 12,521 [8726 women (69.7%); median (interquartile range) age, 49.0 (38.1-58.2) years] fulfilled the inclusion criteria. SSI was identified in 143 patients (1.1%). SAP was administered in 9269 patients (74.0%) and was associated with a lower SSI rate (adjusted odds ratio, 0.50; 95% CI, 0.35-0.70; P < 0.001). The number needed to treat to prevent 1 SSI episode is 100.</p><p><strong>Conclusions: </strong>The overall LR-CCE SSI rate was 1.1%. SAP was associated with a 50% lower overall SSI rate. Patients undergoing LR-CCE may benefit from routine SAP.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"136-141"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2024-06-28DOI: 10.1097/SLA.0000000000006427
Yu-Li Lin, Bradley Herring, Alexander Melamed, Abbas M Hassan, Laura A Petrillo, Nancy L Keating, Anaeze C Offodile
Objective: To assess the association between the Global Budget Revenue (GBR) payment model and shifts to the outpatient setting for surgical procedures among Medicare fee-for-service beneficiaries in Maryland versus control states.
Background: The GBR model provides fixed global payments to hospitals to reduce spending growth and incentivize hospitals to reduce the costs of care while improving care quality. Since surgical care is a major contributor to hospital spending, the GBR model might accelerate the ongoing shift from the inpatient to the outpatient setting to generate additional savings.
Methods: A difference-in-differences (DiD) design was used to compare changes in surgical care settings over time from pre-GBR (2011-2013) to post-GBR (2014-2018) for Maryland versus control states for common surgeries that could be performed in the outpatient setting. A cross-sectional approach was used to compare the difference in care settings in 2018 for total knee arthroplasty which was on Medicare's Inpatient-Only List before then.
Results: We studied 47,542 surgical procedures from 44,410 beneficiaries in Maryland and control states. GBR's 2014 implementation was associated with an acceleration in the shift from inpatient to outpatient settings for surgical procedures in Maryland (DiD: 3.9 percentage points, 95% CI: 2.3, 5.4). Among patients undergoing total knee arthroplasty in 2018, the proportion of outpatient surgeries in Maryland was substantially higher than that in control states (difference: 27.6 percentage points, 95% CI: 25.6, 29.6).
Conclusions: Implementing Maryland's GBR payment model was associated with an acceleration in the shift from inpatient to outpatient hospital settings for surgical procedures.
{"title":"Maryland's Global Budget Revenue Payment Model and Shifts in the Surgical Site of Care Among Medicare Beneficiaries.","authors":"Yu-Li Lin, Bradley Herring, Alexander Melamed, Abbas M Hassan, Laura A Petrillo, Nancy L Keating, Anaeze C Offodile","doi":"10.1097/SLA.0000000000006427","DOIUrl":"10.1097/SLA.0000000000006427","url":null,"abstract":"<p><strong>Objective: </strong>To assess the association between the Global Budget Revenue (GBR) payment model and shifts to the outpatient setting for surgical procedures among Medicare fee-for-service beneficiaries in Maryland versus control states.</p><p><strong>Background: </strong>The GBR model provides fixed global payments to hospitals to reduce spending growth and incentivize hospitals to reduce the costs of care while improving care quality. Since surgical care is a major contributor to hospital spending, the GBR model might accelerate the ongoing shift from the inpatient to the outpatient setting to generate additional savings.</p><p><strong>Methods: </strong>A difference-in-differences (DiD) design was used to compare changes in surgical care settings over time from pre-GBR (2011-2013) to post-GBR (2014-2018) for Maryland versus control states for common surgeries that could be performed in the outpatient setting. A cross-sectional approach was used to compare the difference in care settings in 2018 for total knee arthroplasty which was on Medicare's Inpatient-Only List before then.</p><p><strong>Results: </strong>We studied 47,542 surgical procedures from 44,410 beneficiaries in Maryland and control states. GBR's 2014 implementation was associated with an acceleration in the shift from inpatient to outpatient settings for surgical procedures in Maryland (DiD: 3.9 percentage points, 95% CI: 2.3, 5.4). Among patients undergoing total knee arthroplasty in 2018, the proportion of outpatient surgeries in Maryland was substantially higher than that in control states (difference: 27.6 percentage points, 95% CI: 25.6, 29.6).</p><p><strong>Conclusions: </strong>Implementing Maryland's GBR payment model was associated with an acceleration in the shift from inpatient to outpatient hospital settings for surgical procedures.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"115-121"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2024-07-24DOI: 10.1097/SLA.0000000000006439
Shannon M Ruzycki, Oluwatomilyo Daodu, Selphee Tang, Maede Ejaredar, Kirstie Lithgow, Tyrone G Harrison, Erin A Brennand
Objective: To estimate the association between surgeon sex with surgical postponements or cancelations.
Background: Female surgeons receive lower hourly, per-patient, and total compensation than their male colleagues. Bias in the decision to postpone or cancel surgical cases may contribute to compensation inequality, since this results in unpaid surgeon time.
Methods: This retrospective cohort study used administrative health data to identify surgeries performed at 4 hospitals in Calgary, Alberta, Canada, that were canceled or postponed due to surgeon/operating room overbooking or to accommodate an emergency case between April 1, 2015 and March 31, 2020. Surgeries performed in dedicated operating or procedure rooms (eg, bronchoscopy, cardiac surgery, etc) were excluded. The exposure of interest was surgeon sex, identified by matching their name to the provincial regulatory body record of self-identified sex, which allowed for selection between female and male only during the time of this study.
Results: There were 214,832 eligible surgical cases, of which 1481 and 2473 were postponed or canceled due to overbooking and to accommodate an emergency, respectively. After adjusting for surgical specialty, whether the procedure was a day case, and for patient sex, female surgeons were more likely to be canceled or postponed to accommodate an emergency case compared with male surgeons (odds ratio: 1.21, 95% CI: 1.05-1.38).
Conclusions: There may be sex bias in the decision about which surgical cases to postpone or cancel to accommodate emergency surgeries in our setting. This bias may contribute to compensation inequality in a fee-for-service setting.
{"title":"Surgical Cancelations and Postponements by Surgeon and Patient Sex: A Retrospective Cohort Study in Alberta, Canada.","authors":"Shannon M Ruzycki, Oluwatomilyo Daodu, Selphee Tang, Maede Ejaredar, Kirstie Lithgow, Tyrone G Harrison, Erin A Brennand","doi":"10.1097/SLA.0000000000006439","DOIUrl":"10.1097/SLA.0000000000006439","url":null,"abstract":"<p><strong>Objective: </strong>To estimate the association between surgeon sex with surgical postponements or cancelations.</p><p><strong>Background: </strong>Female surgeons receive lower hourly, per-patient, and total compensation than their male colleagues. Bias in the decision to postpone or cancel surgical cases may contribute to compensation inequality, since this results in unpaid surgeon time.</p><p><strong>Methods: </strong>This retrospective cohort study used administrative health data to identify surgeries performed at 4 hospitals in Calgary, Alberta, Canada, that were canceled or postponed due to surgeon/operating room overbooking or to accommodate an emergency case between April 1, 2015 and March 31, 2020. Surgeries performed in dedicated operating or procedure rooms (eg, bronchoscopy, cardiac surgery, etc) were excluded. The exposure of interest was surgeon sex, identified by matching their name to the provincial regulatory body record of self-identified sex, which allowed for selection between female and male only during the time of this study.</p><p><strong>Results: </strong>There were 214,832 eligible surgical cases, of which 1481 and 2473 were postponed or canceled due to overbooking and to accommodate an emergency, respectively. After adjusting for surgical specialty, whether the procedure was a day case, and for patient sex, female surgeons were more likely to be canceled or postponed to accommodate an emergency case compared with male surgeons (odds ratio: 1.21, 95% CI: 1.05-1.38).</p><p><strong>Conclusions: </strong>There may be sex bias in the decision about which surgical cases to postpone or cancel to accommodate emergency surgeries in our setting. This bias may contribute to compensation inequality in a fee-for-service setting.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"130-135"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695292/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141750863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2024-07-11DOI: 10.1097/SLA.0000000000006438
Krystle K Campbell, Andres A Abreu, Herbert J Zeh, William C Daniel, Vanessa N Palter, Samantha J Bishop, Suzanne Sims, Jaffer M Odeh, Kim Evans, Priya Dandekar, Daniel J Scott
Objective: The purpose of this study was to determine quality improvement outcomes following the pilot implementation of an in-situ simulation designed to enhance surgical safety checklist performance.
Background: OR Black Box (ORBB) technology allows near real-time assessment for surgical safety checklist performance. Before our study, timeout quality was 73.3%, compliance was 99.9%, and engagement was 89.7% (n=1993 cases); Debrief Quality was 76.0%, compliance was 66.9%, and engagement was 66.7% (n=1842 cases).
Methods: This IRB-approved study used prospective convergent multi-methods. During 2 months, a 15-minute in-situ simulation, incorporating rapid cycle deliberate practice, was implemented for OR teams. ORBB analytics generated Timeout and Debrief scores for actual operations performed by surgeons who participated in simulation (Sim-group) versus those who did not (No-sim group) over 6 months, including 2 months pre-intervention, during-intervention, and post-intervention. Inductive content analysis was performed based on simulation discussions to determine team member perspectives.
Results: Thirty simulations with 163 interprofessional participants were conducted. ORBB data from 1570 cases were analyzed. Scores were significantly better for the Sim-group compared with the No-sim group for debrief quality (84% vs. 79% P <0.001, during-intervention), compliance (73% vs. 66%, P <0.001, post-intervention), and engagement (80% vs. 73%, P =0.012, during-intervention). There were no between-group differences for Timeout scores. Thematic analysis identified 2 primary categories: "culture of safety" and "policy."
Conclusions: This simulation-based QI intervention created a psychologically safe training environment for OR teams. The novel use of ORBB technology facilitated outcome analysis and showed significantly better Debrief scores for simulation-trained surgeons compared with nontrained surgeons.
{"title":"Using OR Black Box Technology to Determine Quality Improvement Outcomes for In-situ Timeout and Debrief Simulation.","authors":"Krystle K Campbell, Andres A Abreu, Herbert J Zeh, William C Daniel, Vanessa N Palter, Samantha J Bishop, Suzanne Sims, Jaffer M Odeh, Kim Evans, Priya Dandekar, Daniel J Scott","doi":"10.1097/SLA.0000000000006438","DOIUrl":"10.1097/SLA.0000000000006438","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to determine quality improvement outcomes following the pilot implementation of an in-situ simulation designed to enhance surgical safety checklist performance.</p><p><strong>Background: </strong>OR Black Box (ORBB) technology allows near real-time assessment for surgical safety checklist performance. Before our study, timeout quality was 73.3%, compliance was 99.9%, and engagement was 89.7% (n=1993 cases); Debrief Quality was 76.0%, compliance was 66.9%, and engagement was 66.7% (n=1842 cases).</p><p><strong>Methods: </strong>This IRB-approved study used prospective convergent multi-methods. During 2 months, a 15-minute in-situ simulation, incorporating rapid cycle deliberate practice, was implemented for OR teams. ORBB analytics generated Timeout and Debrief scores for actual operations performed by surgeons who participated in simulation (Sim-group) versus those who did not (No-sim group) over 6 months, including 2 months pre-intervention, during-intervention, and post-intervention. Inductive content analysis was performed based on simulation discussions to determine team member perspectives.</p><p><strong>Results: </strong>Thirty simulations with 163 interprofessional participants were conducted. ORBB data from 1570 cases were analyzed. Scores were significantly better for the Sim-group compared with the No-sim group for debrief quality (84% vs. 79% P <0.001, during-intervention), compliance (73% vs. 66%, P <0.001, post-intervention), and engagement (80% vs. 73%, P =0.012, during-intervention). There were no between-group differences for Timeout scores. Thematic analysis identified 2 primary categories: \"culture of safety\" and \"policy.\"</p><p><strong>Conclusions: </strong>This simulation-based QI intervention created a psychologically safe training environment for OR teams. The novel use of ORBB technology facilitated outcome analysis and showed significantly better Debrief scores for simulation-trained surgeons compared with nontrained surgeons.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"122-129"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141578808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2024-06-21DOI: 10.1097/SLA.0000000000006407
Rosa Klotz, Thomas Hank, Miklos P Berente, Maximilian Joos, Ulf Hinz, Frank Pianka, Benedict Kinny-Köster, Mohammed Al-Saeedi, Oliver Strobel, Thilo Hackert, Martin Schneider, Beat Müller-Stich, Christoph Berchtold, Arianeb Mehrabi, Martin Loos, Markus W Büchler
Objective: To compare short-term outcomes and survival in patients undergoing pancreatic head resection after preoperative endoscopic stenting (ES) versus preoperative surgical drainage (SD) through T-tube insertion.
Background: Patients with pancreatic cancer and obstructive jaundice routinely undergo ES placement. It is well known that ES causes bacterial contamination and infectious complications after pancreatic resection.
Methods: Patients with obstructive jaundice who underwent SD or ES from 2016 to 2022 were identified from a prospective database. Outcome analyses included microbiological bile contamination, overall morbidity, and assessment of the overall complication burden using the Comprehensive Complication Index. Overall survival was investigated by Kaplan-Meier analysis.
Results: A total of 55 patients who underwent SD were identified and matched with 110 patients who underwent ES. After the primary intervention, patients who underwent ES experienced more complications (ES: 17.3% vs SD: 3.6%; P = 0.013). The overall complication burden after pancreatic resection was higher in patients who underwent ES than in patients who underwent SD (Comprehensive Complication Index: 27.2 vs 19.9; P = 0.022). In addition, bacterial contamination of the bile was more frequent in patients who underwent ES compared with individuals who underwent SD (94.3% vs 7.1%; P < 0.001) with similar bacteria in 83.3% of postoperative abdominal infections in patients who underwent ES. While overall survival did not differ between the two groups, patients with postinterventional complications after ES had impaired survival compared with those without complications (11.3 vs 20.4 mo; P = 0.03).
Conclusions: SD for obstructive jaundice in resectable pancreatic cancer is associated with a lower overall complication burden. In addition, patients with complications after ES experience worse overall survival. These findings indicate a rethink of our standards of treatment of obstructive jaundice in patients with pancreatic cancer.
背景:胰腺癌和梗阻性黄疸患者通常要接受内镜支架置入术(ES)。众所周知,内镜支架置入术会导致细菌污染和胰腺切除术后感染并发症:比较接受胰头切除术的患者在术前 ES 与术前通过插入 T 型管进行手术引流(SD)后的短期疗效和存活率:从前瞻性数据库中筛选出2016年至2022年期间接受SD或ES手术的梗阻性黄疸患者。结果分析包括微生物胆汁污染、总体发病率以及使用综合并发症指数(CCI)评估总体并发症负担。总生存率通过卡普兰-梅尔分析法进行研究:结果:共发现 55 例 SD 患者,并与 110 例 ES 患者进行了配对。主要干预后,ES 患者经历了更多的并发症(ES:17.3% 对 SD:3.6%;P=0.013)。ES患者胰腺切除术后的总体并发症负担高于SD患者(CCI:27.2 vs. 19.9;P=0.022)。此外,与 SD 患者相比,ES 患者胆汁受细菌污染的频率更高(94.3% 对 7.1%;PConclusion:可切除胰腺癌梗阻性黄疸的 SD 与较低的总体并发症负担相关。此外,ES 后出现并发症的患者总生存率较低。这些发现表明,我们应该重新考虑胰腺癌患者梗阻性黄疸的治疗标准。
{"title":"Preoperative Surgical or Endoscopic Bile Duct Drainage in Pancreatic Cancer.","authors":"Rosa Klotz, Thomas Hank, Miklos P Berente, Maximilian Joos, Ulf Hinz, Frank Pianka, Benedict Kinny-Köster, Mohammed Al-Saeedi, Oliver Strobel, Thilo Hackert, Martin Schneider, Beat Müller-Stich, Christoph Berchtold, Arianeb Mehrabi, Martin Loos, Markus W Büchler","doi":"10.1097/SLA.0000000000006407","DOIUrl":"10.1097/SLA.0000000000006407","url":null,"abstract":"<p><strong>Objective: </strong>To compare short-term outcomes and survival in patients undergoing pancreatic head resection after preoperative endoscopic stenting (ES) versus preoperative surgical drainage (SD) through T-tube insertion.</p><p><strong>Background: </strong>Patients with pancreatic cancer and obstructive jaundice routinely undergo ES placement. It is well known that ES causes bacterial contamination and infectious complications after pancreatic resection.</p><p><strong>Methods: </strong>Patients with obstructive jaundice who underwent SD or ES from 2016 to 2022 were identified from a prospective database. Outcome analyses included microbiological bile contamination, overall morbidity, and assessment of the overall complication burden using the Comprehensive Complication Index. Overall survival was investigated by Kaplan-Meier analysis.</p><p><strong>Results: </strong>A total of 55 patients who underwent SD were identified and matched with 110 patients who underwent ES. After the primary intervention, patients who underwent ES experienced more complications (ES: 17.3% vs SD: 3.6%; P = 0.013). The overall complication burden after pancreatic resection was higher in patients who underwent ES than in patients who underwent SD (Comprehensive Complication Index: 27.2 vs 19.9; P = 0.022). In addition, bacterial contamination of the bile was more frequent in patients who underwent ES compared with individuals who underwent SD (94.3% vs 7.1%; P < 0.001) with similar bacteria in 83.3% of postoperative abdominal infections in patients who underwent ES. While overall survival did not differ between the two groups, patients with postinterventional complications after ES had impaired survival compared with those without complications (11.3 vs 20.4 mo; P = 0.03).</p><p><strong>Conclusions: </strong>SD for obstructive jaundice in resectable pancreatic cancer is associated with a lower overall complication burden. In addition, patients with complications after ES experience worse overall survival. These findings indicate a rethink of our standards of treatment of obstructive jaundice in patients with pancreatic cancer.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"142-148"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12695368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2024-08-15DOI: 10.1097/SLA.0000000000006504
Andrew P Loehrer, Saania Mirpuri, Oluwadamilola M Fayanju
{"title":"The Pathology of Poverty: Social Conditions Driving Breast Cancer Inequity at the Level of Tumor Biology.","authors":"Andrew P Loehrer, Saania Mirpuri, Oluwadamilola M Fayanju","doi":"10.1097/SLA.0000000000006504","DOIUrl":"10.1097/SLA.0000000000006504","url":null,"abstract":"","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"e1-e2"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12264799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-06-13DOI: 10.1097/SLA.0000000000006788
Miquell Miller, Rachel Ekaireb, Alexis Woods, Elizabeth Wick, Ankit Sarin
{"title":"Telehealth Policy and Rural-Urban Disparities in Cancer Care Access.","authors":"Miquell Miller, Rachel Ekaireb, Alexis Woods, Elizabeth Wick, Ankit Sarin","doi":"10.1097/SLA.0000000000006788","DOIUrl":"10.1097/SLA.0000000000006788","url":null,"abstract":"","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"40-42"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-31DOI: 10.1097/SLA.0000000000007003
Kui Chen, Zhihao Li, Bianca O Kirsh, Ping Luo, Stephanie Pedersen, Roxana C Bucur, Nadia A Rukavina, Jeffrey P Bruce, Arnavaz Danesh, Mazdak Riverin, Sandra E Fischer, Mamatha Bhat, Nazia Selzner, Sonya A MacParland, Carol-Anne Moulton, Steven Gallinger, Ian D McGilvray, Mark S Cattral, Markus Selzner, Trevor W Reichman, Chaya Shwaartz, Blayne A Sayed, Sean P Cleary, Gonzalo Sapisochin, Anand Ghanekar, Trevor J Pugh
Objective: To evaluate the utility of cfMeDIP-seq for detecting hepatocellular carcinoma (HCC) and monitoring recurrence following curative-intent liver surgery.
Summary background data: HCC remains a leading cause of cancer mortality, with high recurrence rates after surgery. Current surveillance depends on imaging and tumor-informed genomics, both limited by sensitivity and tissue access. A tumor-agnostic, noninvasive cfDNA-based method could significantly improve clinical management.
Methods: 236 cfDNA samples were collected at surgery (b-HCC, n=89) and follow-up (f-HCC, n=112) from 89 HCC patients undergoing liver transplantation (n=57) or resection (n=32), plus 35 healthy controls (CTL). cfMeDIP-seq was performed followed by machine learning to: (i) develop an HCC-specific classifier in a discovery cohort (52 b-HCC vs. 35 CTL); (ii) test the classifier in a validation cohort of 37 patients; and (iii) assign an HCC methylation score (HMS) reflecting the probability of a sample containing HCC-derived cfDNA. Relationships between HMS and clinical variables were assessed.
Results: The classifier identified HCC with 97% sensitivity and 99% specificity in the discovery cohort and 97% accuracy in the validation cohort. Baseline HMS >0.9 was associated with higher recurrence risk (HR 3.43, 95% CI 1.30-9.06, P=0.013). HMS decreased by 3-44% (median 17%) within 13 weeks post-surgery. HMS trajectories diverged for recurrent and non-recurrent patients, with HMS rise indicating clinical recurrence. HMS was independent of other clinicopathologic variables.
Conclusion: Tumor-agnostic cfDNA methylomes accurately detect HCC and predict recurrence after liver resection or transplantation. This approach may have important implications for HCC diagnosis, treatment, and monitoring.
目的:评价cfMeDIP-seq在肝手术后肝细胞癌(HCC)检测和复发监测中的应用价值。摘要背景资料:HCC仍然是癌症死亡的主要原因,术后复发率高。目前的监测依赖于成像和肿瘤信息基因组学,两者都受到敏感性和组织获取的限制。一种肿瘤不可知、无创的基于cfdna的方法可以显著改善临床管理。方法:从89例接受肝移植(n=57)或肝切除(n=32)的肝癌患者和35例健康对照(CTL)中收集236份cfDNA样本(b-HCC, n=89)和随访(f-HCC, n=112)。cfMeDIP-seq之后进行机器学习,以:(i)在发现队列中开发hcc特异性分类器(52 b-HCC vs 35 CTL);(ii)在37例患者的验证队列中测试分类器;(iii)分配HCC甲基化评分(HMS),反映样本中含有HCC衍生cfDNA的可能性。评估HMS与临床变量之间的关系。结果:该分类器在发现队列中识别HCC的灵敏度为97%,特异性为99%,在验证队列中准确率为97%。基线HMS >.9与较高的复发风险相关(HR 3.43, 95% CI 1.30-9.06, P=0.013)。术后13周内HMS下降3-44%(中位17%)。复发和非复发患者的HMS轨迹不同,HMS上升表明临床复发。HMS独立于其他临床病理变量。结论:与肿瘤无关的cfDNA甲基组能准确检测HCC并预测肝切除或移植后的复发。这种方法可能对HCC的诊断、治疗和监测具有重要意义。
{"title":"Plasma Cell-free DNA Methylomes for Hepatocellular Carcinoma Detection and Monitoring After Liver Resection or Transplantation.","authors":"Kui Chen, Zhihao Li, Bianca O Kirsh, Ping Luo, Stephanie Pedersen, Roxana C Bucur, Nadia A Rukavina, Jeffrey P Bruce, Arnavaz Danesh, Mazdak Riverin, Sandra E Fischer, Mamatha Bhat, Nazia Selzner, Sonya A MacParland, Carol-Anne Moulton, Steven Gallinger, Ian D McGilvray, Mark S Cattral, Markus Selzner, Trevor W Reichman, Chaya Shwaartz, Blayne A Sayed, Sean P Cleary, Gonzalo Sapisochin, Anand Ghanekar, Trevor J Pugh","doi":"10.1097/SLA.0000000000007003","DOIUrl":"https://doi.org/10.1097/SLA.0000000000007003","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the utility of cfMeDIP-seq for detecting hepatocellular carcinoma (HCC) and monitoring recurrence following curative-intent liver surgery.</p><p><strong>Summary background data: </strong>HCC remains a leading cause of cancer mortality, with high recurrence rates after surgery. Current surveillance depends on imaging and tumor-informed genomics, both limited by sensitivity and tissue access. A tumor-agnostic, noninvasive cfDNA-based method could significantly improve clinical management.</p><p><strong>Methods: </strong>236 cfDNA samples were collected at surgery (b-HCC, n=89) and follow-up (f-HCC, n=112) from 89 HCC patients undergoing liver transplantation (n=57) or resection (n=32), plus 35 healthy controls (CTL). cfMeDIP-seq was performed followed by machine learning to: (i) develop an HCC-specific classifier in a discovery cohort (52 b-HCC vs. 35 CTL); (ii) test the classifier in a validation cohort of 37 patients; and (iii) assign an HCC methylation score (HMS) reflecting the probability of a sample containing HCC-derived cfDNA. Relationships between HMS and clinical variables were assessed.</p><p><strong>Results: </strong>The classifier identified HCC with 97% sensitivity and 99% specificity in the discovery cohort and 97% accuracy in the validation cohort. Baseline HMS >0.9 was associated with higher recurrence risk (HR 3.43, 95% CI 1.30-9.06, P=0.013). HMS decreased by 3-44% (median 17%) within 13 weeks post-surgery. HMS trajectories diverged for recurrent and non-recurrent patients, with HMS rise indicating clinical recurrence. HMS was independent of other clinicopathologic variables.</p><p><strong>Conclusion: </strong>Tumor-agnostic cfDNA methylomes accurately detect HCC and predict recurrence after liver resection or transplantation. This approach may have important implications for HCC diagnosis, treatment, and monitoring.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":""},"PeriodicalIF":6.4,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145861793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1097/sla.0000000000007007
Rachael Acker,Lisa McElroy,Ginny L Bumgardner,Mary T Hawn,Jeffrey B Matthews,Rachel R Kelz
{"title":"An Entrustable Professional Activity for Research in Surgical Residency Training.","authors":"Rachael Acker,Lisa McElroy,Ginny L Bumgardner,Mary T Hawn,Jeffrey B Matthews,Rachel R Kelz","doi":"10.1097/sla.0000000000007007","DOIUrl":"https://doi.org/10.1097/sla.0000000000007007","url":null,"abstract":"","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"29 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145813468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1097/sla.0000000000006998
Ingmar F Rompen,Joseph R Habib,Alessio Marchetti,Elisabetta Sereni,Jin He,D Brock Hewitt,Greg D Sacks,Katherine Morgan,Ammar A Javed,Christopher L Wolfgang
AIMTo evaluate whether transitional circulating tumor cells (trCTCs) predict systemic recurrence of pancreatic ductal adenocarcinoma (PDAC) and assess their potential role in risk stratification for systemic treatment.BACKGROUNDThe high metastatic potential of PDAC is believed to be associated with early dissemination after cancer cell reprogramming via an epithelial-to-mesenchymal transition. These cells are detectable in circulation as trCTCs and could serve as valuable biomarker capturing systemic disease involvement.METHODSThe prospective CLUSTER trial enrolled patients scheduled for PDAC resection (2016-2018). Pre- and postoperative CTCs were isolated with the Isolation-by-SizE-of-Tumor-Cells device and characterized by immunofluorescence. Cox regression with spline terms assessed associations between preoperative biomarkers and systemic recurrence, while multivariable subgroup analyses with interaction tests evaluated overall survival (OS) stratified by adjuvant chemotherapy.RESULTSIn preoperative samples, trCTCs were detected in 82 (67%) of 123 patients with a median number of two cells per ml (IQR 1-3). A linear association between preoperative trCTC counts and systemic recurrence (χ²=13.2, P=0.004) was observed, but no relevant correlation with CA19-9 levels was found (Pearson correlation=0.05, 95% CI:-0.13-0.23). Furthermore, trCTC-positivity after resection predicts recurrence and is associated with prolonged OS associated with adjuvant therapy (HR 0.21, 95%CI: 0.09-0.49) after adjustment for tumor stage and neoadjuvant chemotherapy.CONCLUSIONSPreoperatively, higher trCTC counts are associated with increased risk of systemic recurrence, while postoperative presence reflects minimal residual disease. Integrating trCTC assessment alongside currently used biomarkers into the clinical pathway for patients with PDAC could enhance risk stratification and support more personalized treatment decisions.
目的评估移行性循环肿瘤细胞(trCTCs)是否能预测胰腺导管腺癌(PDAC)的全身复发,并评估其在全身治疗的风险分层中的潜在作用。背景:PDAC的高转移潜力被认为与癌细胞重编程后通过上皮到间质转化的早期传播有关。这些细胞作为trctc可在循环中检测到,并可作为捕获全身性疾病的有价值的生物标志物。方法前瞻性CLUSTER试验纳入了计划进行PDAC切除术的患者(2016-2018)。用肿瘤细胞大小分离装置分离术前和术后的ctc,并用免疫荧光法对其进行表征。采用样条项的Cox回归评估了术前生物标志物与全身复发之间的关联,而采用相互作用试验的多变量亚组分析评估了辅助化疗分层的总生存期(OS)。结果术前样本中,123例患者中有82例(67%)检测到trCTCs,中位数为2个/ ml (IQR 1-3)。术前trCTC计数与全身复发呈线性相关(χ²=13.2,P=0.004),但与CA19-9水平无相关性(Pearson相关=0.05,95% CI:-0.13-0.23)。此外,在调整肿瘤分期和新辅助化疗后,术后trctc阳性预测复发,并与辅助治疗相关的OS延长相关(HR 0.21, 95%CI: 0.09-0.49)。结论:手术前,较高的trCTC计数与全身复发的风险增加有关,而术后的存在反映了最小的残留疾病。将trCTC评估与目前使用的生物标志物整合到PDAC患者的临床途径中可以增强风险分层并支持更个性化的治疗决策。
{"title":"Transitional Type Circulating Tumor Cells Predict Systemic Recurrence and Support Risk Stratification for Chemotherapy After Resection of Pancreatic Ductal Adenocarcinoma: Long-term Outcomes of the CLUSTER Trial.","authors":"Ingmar F Rompen,Joseph R Habib,Alessio Marchetti,Elisabetta Sereni,Jin He,D Brock Hewitt,Greg D Sacks,Katherine Morgan,Ammar A Javed,Christopher L Wolfgang","doi":"10.1097/sla.0000000000006998","DOIUrl":"https://doi.org/10.1097/sla.0000000000006998","url":null,"abstract":"AIMTo evaluate whether transitional circulating tumor cells (trCTCs) predict systemic recurrence of pancreatic ductal adenocarcinoma (PDAC) and assess their potential role in risk stratification for systemic treatment.BACKGROUNDThe high metastatic potential of PDAC is believed to be associated with early dissemination after cancer cell reprogramming via an epithelial-to-mesenchymal transition. These cells are detectable in circulation as trCTCs and could serve as valuable biomarker capturing systemic disease involvement.METHODSThe prospective CLUSTER trial enrolled patients scheduled for PDAC resection (2016-2018). Pre- and postoperative CTCs were isolated with the Isolation-by-SizE-of-Tumor-Cells device and characterized by immunofluorescence. Cox regression with spline terms assessed associations between preoperative biomarkers and systemic recurrence, while multivariable subgroup analyses with interaction tests evaluated overall survival (OS) stratified by adjuvant chemotherapy.RESULTSIn preoperative samples, trCTCs were detected in 82 (67%) of 123 patients with a median number of two cells per ml (IQR 1-3). A linear association between preoperative trCTC counts and systemic recurrence (χ²=13.2, P=0.004) was observed, but no relevant correlation with CA19-9 levels was found (Pearson correlation=0.05, 95% CI:-0.13-0.23). Furthermore, trCTC-positivity after resection predicts recurrence and is associated with prolonged OS associated with adjuvant therapy (HR 0.21, 95%CI: 0.09-0.49) after adjustment for tumor stage and neoadjuvant chemotherapy.CONCLUSIONSPreoperatively, higher trCTC counts are associated with increased risk of systemic recurrence, while postoperative presence reflects minimal residual disease. Integrating trCTC assessment alongside currently used biomarkers into the clinical pathway for patients with PDAC could enhance risk stratification and support more personalized treatment decisions.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"46 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145813469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}